Kim, Kun
Fagerström, Josefine
Chen, Gengshi
Lagunova, Zoya
Furuland, Hans
McEwan, Phil
Funding for this research was provided by:
AstraZeneca
Article History
Received: 14 February 2022
Accepted: 29 July 2022
First Online: 12 August 2022
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations. This article is based on previously conducted research and does not involve any new studies of human or animal subjects performed by any of the authors; as such ethics approval and consent to participate were not required.
: Not applicable.
: KK, JF, GC and ZL are employees of AstraZeneca and JF and GC are stock owners of AstraZeneca. PM is an employee of Health Economics and Outcomes Research Ltd. Health Economics and Outcomes Research Ltd. received fees from AstraZeneca in relation to this study. HF has received consultancy fees from AstraZeneca, Boehringer Ingelheim and Novo Nordisk.